Susquehanna International Group, LLP Harpoon Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$3.54 - $8.08 $77,526 - $176,952	-21,900 Reduced 61.34%	13,800 $69,000
Q4 2021 Feb 14, 2022	SELL	$5.69 - $7.83 $128,025 - $176,175	-22,500 Reduced 38.66%	35,700 $270,000
Q3 2021 Nov 15, 2021	BUY	$7.88 - $14.0 $326,232 - $579,600	41,400 Added 246.43%	58,200 $460,000
Q2 2021 Aug 11, 2021	SELL	$13.81 - $23.25 $75,955 - $127,875	-5,500 Reduced 24.66%	16,800 $233,000
Q1 2021 May 17, 2021	BUY	$17.65 - $24.16 $148,260 - $202,944	8,400 Added 60.43%	22,300 $467,000
Q4 2020 Feb 16, 2021	SELL	$12.83 - $17.84 $92,376 - $128,448	-7,200 Reduced 34.12%	13,900 $231,000
Q3 2020 Nov 16, 2020	BUY	$11.01 - $18.52 $232,311 - $390,772	21,100 New	21,100 $358,000

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.